SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $300.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-05
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $300.00K, a 200.00% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $2.50M, a 2400.00% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $2.90M, a 222.22% increase from fiscal 2024.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $900.00K, a 47.06% decline from fiscal 2023.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $1.70M, a 67.92% decline from fiscal 2022.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $5.30M, a 27.40% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $300.00K 10-Q · filed 2026-08-05 | $2.80M derived: sum of 3 quarters · filed 2026-08-05 | $3.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-06 | $2.80M derived: sum of 2 quarters · filed 2026-05-06 | $3.00M derived: sum of 3 quarters · filed 2026-05-06 | $3.10M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.70M derived: sum of 2 quarters · filed 2026-03-04 | $2.80M derived: sum of 3 quarters · filed 2026-03-04 | $2.90M 10-K · filed 2026-03-04 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 | $300.00K derived: sum of 2 quarters · filed 2025-11-06 | $400.00K 10-Q · filed 2025-11-06 | $500.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-07 | $100.00K 10-Q · filed 2025-08-07 | $300.00K derived: sum of 3 quarters · filed 2025-08-07 | $500.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-08 | $200.00K derived: sum of 2 quarters · filed 2025-05-08 | $400.00K derived: sum of 3 quarters · filed 2025-05-08 | $500.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $300.00K derived: sum of 2 quarters · filed 2025-03-07 | $400.00K derived: sum of 3 quarters · filed 2025-03-07 | $900.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $200.00K 10-Q · filed 2024-11-07 | $300.00K derived: sum of 2 quarters · filed 2024-11-07 | $800.00K 10-Q · filed 2024-11-07 | $1.30M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-02 | $700.00K 10-Q · filed 2024-08-02 | $1.10M derived: sum of 3 quarters · filed 2024-08-02 | $1.20M derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | $500.00K 10-Q · filed 2024-05-06 | $1.00M derived: sum of 2 quarters · filed 2024-05-06 | $1.10M derived: sum of 3 quarters · filed 2024-05-06 | $1.60M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $600.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.10M derived: sum of 3 quarters · filed 2024-03-13 | $1.70M 10-K · filed 2024-03-13 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-07 | $600.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.20M 10-Q · filed 2023-11-07 | $1.90M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $500.00K 10-Q · filed 2023-08-07 | $1.00M 10-Q · filed 2023-08-07 | $1.80M derived: sum of 3 quarters · filed 2023-08-07 | $3.50M derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | $600.00K 10-Q · filed 2023-05-08 | $1.30M derived: sum of 2 quarters · filed 2023-05-08 | $3.00M derived: sum of 3 quarters · filed 2023-05-08 | $4.70M derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.40M derived: sum of 2 quarters · filed 2023-03-16 | $4.10M derived: sum of 3 quarters · filed 2023-03-16 | $5.30M 10-K · filed 2023-03-16 |
| 2022-09-30 | $1.70M 10-Q · filed 2022-11-10 | $3.40M derived: sum of 2 quarters · filed 2022-11-10 | $4.60M 10-Q · filed 2022-11-10 | $7.70M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $1.70M 10-Q · filed 2022-08-11 | $2.90M 10-Q · filed 2022-08-11 | $6.00M derived: sum of 3 quarters · filed 2022-08-11 | $6.90M derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | $1.20M 10-Q · filed 2022-05-10 | $4.30M derived: sum of 2 quarters · filed 2022-05-10 | $5.20M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2021-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $4.00M derived: sum of 2 quarters · filed 2022-03-24 | $7.30M 10-K · filed 2022-03-24 | |
| 2021-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.20M 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $3.30M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |